Membership Commentary

DRAFT United States Industry Consensus Standard for the Uniform Labeling of Cellular Therapy Products using ISBT 128, Version 1.0.0

The DRAFT United States Industry Consensus Standard for the Uniform Labeling of Cellular Therapy Products using ISBT 128, Version 1.0.0 is the result of the collaborative efforts of AABB, ASBMT, ASFA, FACT, ICCBBA, ISCT, and NMDP.

It is available for general comment until August 1, 2008.  All comments will be taken into consideration prior to the final publication of the document.

ASFA had decided to collate all comments and to send it as an official document representing ASFA.  You are welcome to send your comments until July 1, 2008.  The document may be found by clicking here.

Please send your comments to the Head Office at asfa@apheresis.org.